Description
A prodrug for the Hsp90 inhibitor, PF-04958473 (SNX-2112), which binds both Hsp90α and Hsp90β with an IC50 value of 30 nM; reduces tumor growth and prolongs survival in mouse models of multiple myeloma and prostate cancer when given orally